Virbac SA (EPA: VIRP)

Market Cap	2.59B
Revenue (ttm)	1.34B
Net Income (ttm)	141.19M
Shares Out	8.37M
EPS (ttm)	16.81
PE Ratio	18.41
Forward PE	15.94
Dividend	1.32 (0.43%)
Ex-Dividend Date	Jun 25, 2024

Volume	4,264
Open	310.50
Previous Close	312.00
Day's Range	306.00 - 311.50
52-Week Range	306.00 - 400.00
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 12, 2025

About Virbac

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1968
• Employees: 5,459
• Stock Exchange: Euronext Paris
• Ticker Symbol: VIRP

Financial Performance

In 2023, Virbac's revenue was 1.25 billion, an increase of 2.53% compared to the previous year's 1.22 billion. Earnings were 121.30 million, a decrease of -0.53%.